Relevant bibliographies by topics / HCV virus

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'HCV virus'

Author: Grafiati
Published: 24 April 2022
Last updated: 30 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'HCV virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "HCV virus"

1

Shen, Yu-Chuan, Hui-Ching Hsu, Tzu-Min Lin, et al. "H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection." Journal of Clinical Oncology 40, no. 11 (2022): 1206–19. http://dx.doi.org/10.1200/jco.21.01802.

Full text
Abstract:
PURPOSE H1-antihistamines (AHs) may exert protective effects against cancer. This study investigated the association of AH use with the risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or dual HBV-HCV virus infection. MATERIALS AND METHODS Patients with HBV, HCV, or dual HBV-HCV infection were enrolled from Taiwan's National Health Insurance Research Database and examined for the period from January 1, 2006, to December 31, 2015. We used the Kaplan-Meier method and Cox proportional hazards regression to evaluate the association between A
APA, Harvard, Vancouver, ISO, and other styles
2

Lu, Meng-Chuan, Ying-Hsuen Wu, Chi-Hsiang Chung, et al. "Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma." Journal of Clinical Medicine 12, no. 7 (2023): 2602. http://dx.doi.org/10.3390/jcm12072602.

Full text
Abstract:
Background: Hepatocellular carcinoma accounts for approximately 90% of primary liver cancers and hepatitis virus was believed to have the potential for altering the pathogenesis of arteriosclerosis. However, the influence of the hepatitis virus on coronary artery disease or cerebral vascular disease remains unclear. This study used the Taiwan National Health Insurance Research Database to clarify the virus-associated risk of coronary artery disease and cerebral vascular disease in patients with hepatocellular carcinoma (HCC). Methods: A total of 188,039 HCC individuals, age 20 years or older,
APA, Harvard, Vancouver, ISO, and other styles
3

Petruzziello, Arnolfo. "Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma." Open Virology Journal 12, no. 1 (2018): 26–32. http://dx.doi.org/10.2174/1874357901812010026.

Full text
Abstract:
Introduction:Hepatocellular carcinoma (HCC) is one of the most prevalent primary malignant tumors and accounts for about 90% of all primary liver cancers. Its distribution varies greatly according to geographic location and it is more common in middle and low- income countries than in developed ones especially in Eastern Asia and Sub Saharan Africa (70% of all new HCCs worldwide), with incidence rates of over 20 per 100,000 individuals.Explanation:The most important risk factors for HCC are Hepatitis B Virus (HBV) infection, Hepatitis C Virus (HCV) infection, excessive consumption of alcohol a
APA, Harvard, Vancouver, ISO, and other styles
4

Alhamadany, Alaa Younis Mahdy, and Wajdi Sabeeh Sadek. "Analysis of the Chromosomal Aberrations in Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Hepatocellular Carcinoma Patients (HCC) in Mosul City, Iraq." NTU Journal of Pure Sciences 1, no. 2 (2022): 48–53. http://dx.doi.org/10.56286/ntujps.v1i2.210.

Full text
Abstract:
Abstract. Hepatocellular carcinoma (HCC) (also known as liver cancer) is one of the most frequent cancers in humans. HCC is linked to chronic hepatitis B and C virus infection, cirrhosis, and excessive alcohol consumption. The aim of this study was to use Metaphase chromosome analysis in whole blood to determine chromosomal aberrations (CA) in HBV, HCV, and HCC patients. A cohort of 145 samples have been collected from participants from the date of 5 \ 1 \ 2020 to 15\9\ 2021. Among those samples are (40 healthy controls, HBV 38, 44 HCV, and HCC 23) to make cytogenetic evaluation by observing t
APA, Harvard, Vancouver, ISO, and other styles
5

Dickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann, and Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection." European Addiction Research 22, no. 4 (2015): 181–91. http://dx.doi.org/10.1159/000441973.

Full text
Abstract:
Background/Aims: We report on the rates of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in 1,313 clients entering heroin-assisted treatment (HAT) in Switzerland from 2003 to 2013. We identify predictors of HCV infection. Methods: Data were collected using questionnaires within 2 weeks of clients' first entry into HAT. Prevalence of HAV, HBV, HCV and HIV was calculated using laboratory test results collected at entry or using reports of older test results. Predictors of HCV status were identified through multiple logistic regre
APA, Harvard, Vancouver, ISO, and other styles
6

Mujeeb, Syed Abdul, Qamar Jamal, Rafique Khanani, Nayyer Iqbal, and Shahnaz Kaher. "Prevalence of Hepatitis B Surface Antigen and HCV Antibodies in Hepatocellular Carcinoma Cases in Karachi, Pakistan." Tropical Doctor 27, no. 1 (1997): 45–46. http://dx.doi.org/10.1177/004947559702700117.

Full text
Abstract:
Hepatocellular carcinoma (HCC) is a common cancer the world over. In Pakistan it has an incidence of 8/100 000 per annum. To assess the prevalence of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections in biopsy proven cases of HCC a serological study was conducted at Screening Laboratory of Blood Transfusion Services, Jinnah Postgraduate Medical Centre. Of 54 sera of HCC tested for HBV and HCV infections, 67% showed HBV infection, and 33% HCV infection. Among them 24% were positive for both HBV and HCV infections. No HBV and HCV infection was found in 24% cases of HCC. Our findings
APA, Harvard, Vancouver, ISO, and other styles
7

Fang, Lily, Amanda Yu, and Jane A. Buxton. "Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007." Canadian Journal of Infectious Diseases and Medical Microbiology 22, no. 1 (2011): 10–14. http://dx.doi.org/10.1155/2011/564290.

Full text
Abstract:
BACKGROUND: In British Columbia (BC), hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccines are provincially funded for persons with chronic hepatitis infections. PURPOSE: To assess the effectiveness of BC public health follow-up of HBV and hepatitis C virus (HCV) cases and immunization policy by determining the number of vaccine-preventable acute hepatitis infections reported following a chronic HBV or HCV diagnosis, by examining demographic characteristics and by observing temporal trends.METHODS: All newly identified cases of HAV, HBV and HCV between 1991 and October 2007 were extrac
APA, Harvard, Vancouver, ISO, and other styles
8

Stroffolini, Tommaso, and Giacomo Stroffolini. "A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma." Cancers 15, no. 8 (2023): 2388. http://dx.doi.org/10.3390/cancers15082388.

Full text
Abstract:
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the leading cause of hepatocellular carcinoma (HCC) worldwide. Currently, HBV-related HCC predominates in Sub-Saharan Africa and South-East-Asia, while HCV-related HCC predominates in northern Africa and in the western world. Liver cirrhosis is the underlying condition in most HBV cases and in nearly all HCV cases. Several cofactors, viral and non-viral, play a role in the progression toward HCC: dual HBV/HCV infection, HDV, HIV, alcohol intake, smoking, diabetes mellitus, obesity, and NAFLD/NASH. HBV vaccine is effective in preventing bo
APA, Harvard, Vancouver, ISO, and other styles
9

Buxton, Jane A., and Jin Hee Kim. "Hepatitis A and Hepatitis B Vaccination Responses in Persons with Chronic Hepatitis C Infections: A Review of the Evidence and Current Recommendations." Canadian Journal of Infectious Diseases and Medical Microbiology 19, no. 2 (2008): 197–202. http://dx.doi.org/10.1155/2008/410362.

Full text
Abstract:
In persons with chronic hepatitis C virus (HCV) infections, superinfection by hepatitis A virus (HAV) or hepatitis B virus (HBV) can cause serious complications, including fulminating hepatitis or increased severity of hepatitis. Therefore, it is important to adequately protect persons with chronic HCV infections by immunization. Suboptimal response to vaccines has been reported in patients with chronic liver disease. The present article reviews HAV and HBV vaccine responses reported in the literature when administered to individuals with chronic HCV infection, and reviews current national and
APA, Harvard, Vancouver, ISO, and other styles
10

Shao, Yu Yun, Min-Shu Hsieh, Chung-Yi Huang, Yung-Ling Chang, Chih-Hung Hsu, and Ann-Lii Cheng. "Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC." Journal of Clinical Oncology 31, no. 15_suppl (2013): 4115. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4115.

Full text
Abstract:
4115 Background: HCC with different etiologic factors may result in activation of different signaling pathways. This study aimed to clarify if HBV-related HCC (HBV-HCC) and HCV-related HCC (HCV-HCC) may have difference in the expression of key molecules that are relevant to contemporary molecular targeted therapy. Methods: We enrolled patients diagnosed with advanced HCC from 2001 to 2011 who had tumor tissues obtained upon the diagnosis of advanced HCC at our center. Tumor slides were immunohistochemically stained for phosphorylated extracellular signal-regulated kinases (p-ERK), Raf kinase i
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "HCV virus"

1

Burke, Stephanie. "Generalized Impairment of CD8+ T-cells in HCV Mono- and HIV-HCV Co-infection." Thesis, Université d'Ottawa / University of Ottawa, 2015. http://hdl.handle.net/10393/32770.

Full text
Abstract:
Chronic hepatitis C virus (HCV) infection has global effects on the immune system. CD8+ T-cells, responsible for viral clearance and control, are dysfunctional for as yet unknown reasons. It is hypothesized that IL-7 signaling pathway deficiencies contribute to this impairment. Blood-derived CD8+ T-cells in chronic HCV mono- and HIV-HCV co-infection had lower IL-7-induced activation of STAT5 and production of Bcl-2, and lower proliferation in co-infection, compared to controls. Lower Bcl-2 production was also associated with increased fibrosis. These changes were independent of the IL-7 recep
APA, Harvard, Vancouver, ISO, and other styles
2

Marraiki, Najat A. Y. "Recombinant virus like particles comprising hepatitis C virus (HCV) structural proteins and HCV replicon RNA." Thesis, University of Leeds, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.422629.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Matsukura, Motoi. "Highly active anti-retroviral therapy and liver mitochondrial toxicity in human immunodeficiency virus / hepatitis C virus co-infection." Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/2517.

Full text
Abstract:
Background: A third of HIV-infected patients are co-infected with HCV in the developed world, and more of co-infected patients than ever before are dying because of liver related diseases today. Drug-related hepatotoxicity is a growing concern among human immunodeficiency virus (HIV) / hepatitis C virus (HCV) co-infected population. Nucleotide analogues containing HIV antiretroviral therapy, namely highly active anti-retroviral therapy (HAART), can induce mitochondrial toxicity. However, little is known about the effect of nucleotide analogues on the liver at the cellular and molecular level,
APA, Harvard, Vancouver, ISO, and other styles
4

Gao, Zhanhai School of Mathematics UNSW. "Modelling Human Immunodeficiency Virus and Hepatitis C Virus Epidemics in Australia." Awarded by:University of New South Wales. School of Mathematics, 2001. http://handle.unsw.edu.au/1959.4/18187.

Full text
Abstract:
This thesis is concerned with the mathematical modelling for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) epidemics in Australia. There are two parts to this thesis. Part I is aimed at modelling the transmission of HIV and HCV via needle sharing among injecting drug users (IDUs). The dynamical model of an epidemic through needle sharing among IDUs is derived. This model reveals the correlation between needle sharing and the epidemic prevalence among IDUs. The simulations of HIV and HCV prevalence and incidence among IDUs in Australia are made with this model. The comparison
APA, Harvard, Vancouver, ISO, and other styles
5

Franco, Kelly Flory. "Hepatitis C virus (HCV) replication in vitroand the effect of HCV on human immunodeficiency virus (HIV-1) coreceptor usage and diversity in the coinfected patient." Cincinnati, Ohio : University of Cincinnati, 2007. http://rave.ohiolink.edu/etdc//view?acc_num=ucin1183474023.

Full text
Abstract:
Thesis (Ph.D.)--University of Cincinnati, 2007.<br>Advisor: Dr. Julie A.E. Nelson. Title from electronic thesis title page (viewed Dec. 22, 2009). Includes abstract. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
6

Reynolds, Joanna Elizabeth. "Initiation of hepatitis C virus RNA translation." Thesis, University of Cambridge, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264546.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Dongsheng. "The role of HCV core protein in the regulation of HCV replication /." St. Lucia, Qld, 2003. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18009.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Da, Costa Daniel. "Study of cell host factors involved in Hepatitis C virus tropism." Thesis, Strasbourg, 2012. http://www.theses.fr/2012STRAJ071/document.

Full text
Abstract:
Le virus de l’hépatite C (HCV) est un problème majeur de santé publique. Le développement de nouveaux traitements pour lutter contre le HCV a été ralenti par l’absence de modèles d’études in vitro et in vivo convenables. Le but de mon travail de thèse a été, dans un premier temps, de caractériser les facteurs déterminant le tropisme hépatique du HCV. En exprimant des facteurs clés dans une lignée cellulaire humaine non-hépatocytaire, nous avons reconstitué in fine l’ensemble du cycle viral dans ces cellules. L’entrée du virus dans la cellule hôte fait intervenir différents récepteurs d’entrée
APA, Harvard, Vancouver, ISO, and other styles
9

Tuthill, Tobias J. "Construction expression and preliminary biological analysis of HCV and HCV-dengue chimeric virus genomes." Thesis, Imperial College London, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.368893.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Paterson, Caren Joan Isabella. "The development of a small animal model for hepatitis C virus (HCV) using chimeric HCV-BVDV (bovine viral diarrhoea virus) replicons." Thesis, Royal Veterinary College (University of London), 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415668.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "HCV virus"

1

Association, Canadian Hospital, ed. Guide to policies for health care facilities and agencies: Bloodborne pathogens, especially Human Immunodeficiency Virus (HIV), Hepatitis B Virus, (HBV) and Hepatitis C Virus (HCV). Canadian Hospital Association, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kiwamu, Okita, ed. HCV/oxidative stress and liver disease. Springer, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Giulio, Pisani, ed. Nucleic acid amplification technology (NAT) for the detection of Hepatitis C Virus (HCV) in plasma pools: Validation report. Istituto superiore di sanità, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Seminario, di aggiornamento sull'epatite da virus HCV e. nuovi virus potenzialmente epatitici: diagnosi epidemiologia prevenzione e. terapia (5th 2000 Rome Italy). V Seminario di aggiornamento sull'epatite da virus HCV e nuovi virus potenzialmente epatitici: Diagnosi, epidemiologia, prevenzione e terapia : Istituto superiore di sanità, Roma, 20-21 dicembre 2000 : atti. Istituto superiore di sanità, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mohamed Hatem Fathi El-Saied Wali. Natural history, factors affecting severity and progression rate of hepatitis c virus (HCV) infection in liver transplanted and non-transplanted patients. University of Birmingham, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Administration, United States Occupational Safety and Health. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

United States. Occupational Safety and Health Administration. Enforcement procedures for occupational exposure to Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). U.S. Dept. of Labor, Assistant Secretary for Occupational Safety and Health, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

South Africa. Department of National Health and Population Development. AIDS: HIV-virus = VIGS. Dept. of National Health and Population Development, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lowe, John W. Human immunodeficiency virus research program. U.S. Army Medical Research, Development, Acquisition and Logistics Command (Provisional), 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "HCV virus"

1

Ingiliz, Patrick, Maud Lemoine, and Yves Benhamou. "Chronic HCV and HIV Coinfection." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Deterding, Katja, Heiner Wedemeyer, and Michael P. Manns. "Acute HCV." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Coffin, Carla S., and Norah A. Terrault. "Treatment of HCV, HDV, or HIV Coinfection." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4843-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhou, Kali, and Norah A. Terrault. "Treatment of HCV, HDV, or HIV Coinfections." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3615-8_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Marcotrigiano, Joseph, and Maria Teresa Catanese. "The Structure of HCV." In Hepatitis C Virus I. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-56098-2_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Su, Wen-Chi, Keigo Machida, and Michael M. C. Lai. "Extrahepatic Replication of HCV." In Hepatitis C Virus II. Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-56101-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Davis, Gary L. "Epidemiology of Chronic HCV." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kronenberger, B., and S. Zeuzem. "Antiviral Targets in HCV." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Torres, Dawn McDowell, and Stephen A. Harrison. "Chronic HCV and Steatosis." In Chronic Hepatitis C Virus. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-1192-5_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ehling, A., B. Gierten, and T. Arndt. "Hepatitis C-Virus (HCV)." In Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1429-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "HCV virus"

1

Süer, Kaya, Omid Mirzaei, Kadir Yelmi, and Aslı Aykaç. "The Relationship Between Drug Addiction and Significant Infectious Diseases." In Panel on "Effective Drug Control Strategies in Northern Cyprus: Challenges and Opportunities in 2024". Emanate Publishing House Ltd., 2024. http://dx.doi.org/10.70020/ehass.2024.7.4.

Full text
Abstract:
Substance addiction can be explained as individuals’ unrestrained desire to consume a substance although such consumption harms their mental, physical, and social lives. Addicts are exposed to stigmatization and discrimination, which limits their ability to get the help they need. In 2021, one in every 17 people between the ages of 15 and 64 was found to be using drugs, which is a 23% increase compared to 10 years ago. In addition to overdose, hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are the leading causes of deaths related to drug use. Research on drug use by gender show
APA, Harvard, Vancouver, ISO, and other styles
2

Hundur Hiyari, Madžida, Nejra Merdović, Faruk Bećirović, Emina Mrđanović, and Adna Softić. "Liver Disease Classification Using Machine Learning." In Artificial Intelligence in Industry 4.0: The future that comes true. Academy of Sciences and Arts of Bosnia and Herzegovina, 2024. http://dx.doi.org/10.5644/pi2024.215.16.

Full text
Abstract:
Hepatitis C virus (HCV) is a significant cause of liver-related diseases including acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Despite the availability of advanced treatments, underdiagnosis remains a critical challenge, particularly in resource-limited settings. This study explores the application of machine learning algorithms, specifically the K-Nearest Neighbors (KNN) method, to enhance the diagnosis of HCV by classifying patients into healthy, potentially diseased, and diseased categories based on liver function test results. Using a biomedical dataset of 615 pat
APA, Harvard, Vancouver, ISO, and other styles
3

Shao, Yu-Yun, Chung-Yi Huang, Jun-Wei Chen, Chih-Hung Hsu, and Ann-Lii Cheng. "Abstract 17: Hepatitis C virus (HCV) core protein potentiates proangiogenic activity of hepatocellular carcinoma (HCC) cells." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Svirin, K. A., O. G. Polovkova, E. S. Fedorova, M. N. Kamalov, A. S. Zheleznova, and M. Yu Kartashov. "ANALYSIS OF RESISTANCE MUTATIONS IN HEPATITIS C VIRUS ISOLATES SUBGENOTYPES 1B AND 3A IN TUBERCULOSIS-INFECTED INDIVIDUALS IN THE TOMSK REGION." In XI МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ МОЛОДЫХ УЧЕНЫХ: БИОИНФОРМАТИКОВ, БИОТЕХНОЛОГОВ, БИОФИЗИКОВ, ВИРУСОЛОГОВ, МОЛЕКУЛЯРНЫХ БИОЛОГОВ И СПЕЦИАЛИСТОВ ФУНДАМЕНТАЛЬНОЙ МЕДИЦИНЫ. IPC NSU, 2024. https://doi.org/10.25205/978-5-4437-1691-6-200.

Full text
Abstract:
Hepatitis C virus (HCV) has high mutational variability, which leads to the emergence of mutational forms that are resistant to direct-acting antivirals. Among 25 isolates of HCV subtype 3a found in tuberculosis patients in the Tomsk region, mutations Y93H and S/T62L were found in the NS5A gene, and A166S/T substitutions were detected in the NS3 gene. In nine isolates of subtype 1b, mutations L31M and P58S were detected in the NS5A gene; substitutions L159F, C316, and S556G were detected in the NS5B gene.
APA, Harvard, Vancouver, ISO, and other styles
5

Menon, Jeevan G., R. Paul Duffin, Richard H. Tullis, and Frank G. Jacobitz. "Hollow-Fiber Cartridges: Model Systems for Virus Removal From Blood." In ASME 2006 Frontiers in Biomedical Devices Conference. ASMEDC, 2006. http://dx.doi.org/10.1115/nanobio2006-18034.

Full text
Abstract:
Aethlon Medical is developing an extracorporeal blood filter as a therapeutic device designed to remove viruses and toxins from the blood of patients. The Hemopurifier is a modified hollow-fiber plasmapheresis cartridge containing an affinity matrix in the extra capillary space. The matrix contains a high mannose specific lectin as the active capture agent. The flow configuration of the device is that of Starling flow. The filter is designed to clear viruses and toxins from blood, delaying illness so the patient’s immune system can fight off the virus. Results to date indicate the efficient re
APA, Harvard, Vancouver, ISO, and other styles
6

"DIFERENCIAS EN EL ACCESO Y EN EL TIEMPO HASTA EL INICIO DE TRATAMIENTO HEPATITIS C EN PERSONAS CON DESORDENES DE SALUD MENTAL." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021o048.

Full text
Abstract:
People who inject drugs (PWID) and other marginalized populations with high hepatitis C virus (HCV) infection rates represent a unique challenge for treatment initiation due to health, administrative and social barriers. We analyzed the HCV cascade of care (CoC) in some vulnerable subpopulations in Madrid, Spain, when using a mobile point of care. to identify gaps and barriers to improve HCV elimination efforts in these populations. Methods: From 2019 to 2021, a mobile unit was used to screen for HCV using a linkage-to-care and two-step point-of-care-based strategy. Viremic participants were g
APA, Harvard, Vancouver, ISO, and other styles
7

Brieva Herrero, MT, I. Reyes Torres, M. Sáez-Torres de Vicente, P. López López, M. Frias Casas, and A. Rivero Juárez. "4CPS-267 Lack of hepatitis C virus uptake in HIV/HCV co-infected patients." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Urda, J., M. Herrera Expósito, A. Jofre Peralta, and MA Castro Vida. "4CPS-090 Efficacy and safety of pangenotypic treatments in hepatitis C virus (HCV) patients." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stuchinskaya, M. D., L. I. Nikolaeva, and N. S. Shastina. "SIGNIFICANCE OF ANTIBODY DETECTION TO B-CELL DETERMINANTS OF ENVELOPE PROTEINS OF HEPATITIS C VIRUS." In XI МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ МОЛОДЫХ УЧЕНЫХ: БИОИНФОРМАТИКОВ, БИОТЕХНОЛОГОВ, БИОФИЗИКОВ, ВИРУСОЛОГОВ, МОЛЕКУЛЯРНЫХ БИОЛОГОВ И СПЕЦИАЛИСТОВ ФУНДАМЕНТАЛЬНОЙ МЕДИЦИНЫ. IPC NSU, 2024. https://doi.org/10.25205/978-5-4437-1691-6-104.

Full text
Abstract:
The aim of the study was to analyze infected human antibody response to peptides reproducing B-cell epitopes of HCV envelope proteins to assess their possible association with virus elimination. The synthesis of peptides was carried out by the solid phase method. According to the results of enzyme-linked immunosorbent assay, it was found that the presence of antibodies to one of the analyzed peptides was associated with achieving a sustained virological response.
APA, Harvard, Vancouver, ISO, and other styles
10

Mischke, Jasmin, Sebastian Klein, Heiner Wedemeyer, Markus Cornberg, and Anke Kraft. "Single cell analysis of HCV and heterologous virus-specific CD8+T cell responses in patients with chronic hepatitis C before and after HCV elimination." In 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760064.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "HCV virus"

1

Tsai, Tsung-Yu, Guan-Jhou Chen, Hsin-Yun Sun, and Chien-Ching Hung. Diagnostic Performance of Hepatitis C Virus Core Antigen for Acute HCV Infection among People with HIV: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.3.0106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Full text
Abstract:
Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/
APA, Harvard, Vancouver, ISO, and other styles
3

Lowe, John W., Francine McCutchan, John McNeil, Ellen Namie, and Richard Daniella. Human Immunodeficiency Virus (HIV) Research - AIDS. Defense Technical Information Center, 1994. http://dx.doi.org/10.21236/ada298062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Redington, Bryce C., and Martha B. Shaw. Human Immunodeficiency Virus (HIV) Research (AIDS). Defense Technical Information Center, 1991. http://dx.doi.org/10.21236/ada236988.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Scobie, Linda, Liam O'Connor, Martin D’Agostino, et al. Thermal Inactivation Model for Hepatitis E Virus (HEV). Food Standards Agency, 2022. http://dx.doi.org/10.46756/sci.fsa.sdt366.

Full text
Abstract:
Hepatitis E is an emerging issue, with the number of confirmed cases in the UK increasing in 2009-2015, and decreasing slightly in 2016 and 2017. There is some epidemiological evidence of an association of this virus with undercooked pork and pork products. Currently, there is no standardized method for evaluating thermal stability of HEV and also a lack of a suitable assay that can distinguish between intact HEV that can cause an infection and damaged virus which is not capable of causing an infection. This has raised concerns as it is extremely difficult to extrapolate the risk from pork pro
APA, Harvard, Vancouver, ISO, and other styles
6

Kasorndorkbua, C., P. J. Thomas, Patrick G. Halbur, D. K. Guenette, F. F. Huang, and X. J. Meng. Infection of Pigs with Avian Hepatitis E Virus (HEV). Iowa State University, 2005. http://dx.doi.org/10.31274/ans_air-180814-1096.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Semaan, Dima, and Linda Scobie. Feasibility study for in vitro analysis of infectious foodborne HEV. Food Standards Agency, 2022. http://dx.doi.org/10.46756/sci.fsa.wfa626.

Full text
Abstract:
Hepatitis E virus (HEV) is a member of the Hepeviridae family capable of infecting humans producing a range of symptoms from mild disease to kidney failure. Epidemiological evidence suggests that hepatitis E genotype III and IV cases may be associated with the consumption of undercooked pork meat, offal and processed products such as sausages [1]. A study carried out by the Animal Health and Veterinary Laboratories Agency (AHVLA), found hepatitis E virus contamination in the UK pork production chain and that 10% of a small sample of retail pork sausages were contaminated with the virus [2]. Fu
APA, Harvard, Vancouver, ISO, and other styles
8

Haider, Huma. Malaria, HIV and TB in Nigeria: Epidemiology and Disease Control Challenges. Institute of Development Studies (IDS), 2021. http://dx.doi.org/10.19088/k4d.2022.040.

Full text
Abstract:
Nigeria has the world’s highest number of people affected by malaria and the world’s second largest human immunodeficiency virus (HIV)/AIDS burden. There is a high occurrence of co-infection of malaria in HIV patients (Gumel et al., 2021). Nigeria is also ranked as one of the thirty high tuberculosis (TB) and TB-HIV co-infection burden countries in the world (Odume et al., 2020, 8). Co-infection can make each disease more severe and potentially more infectious (Gumel et al., 2021; Jemikalajah et al., 2021; Chukwuocha et al., 2019). This rapid literature review highlights key aspects of the epi
APA, Harvard, Vancouver, ISO, and other styles
9

Palukaitis, Peter, Amit Gal-On, Milton Zaitlin, and Victor Gaba. Virus Synergy in Transgenic Plants. United States Department of Agriculture, 2000. http://dx.doi.org/10.32747/2000.7573074.bard.

Full text
Abstract:
Transgenic plants expressing viral genes offer novel means of engendering resistance to those viruses. However, some viruses interact synergistically with other viruses and it is now known that transgenic plants expressing particular genes of one virus may also mediate synergy with a second virus. Thus, our specific objectives were to (1) determine if transgenic plants resistant to one virus showed synergy with another virus; (2) determine what viral sequences were essential for synergy; and (3) determine whether one of more mechanisms were involved i synergy. This project would also enable an
APA, Harvard, Vancouver, ISO, and other styles
10

Library, Spring. How Close are We Really to the HIV Cure? Spring Library, 2020. http://dx.doi.org/10.47496/sl.blog.20.

Full text
Abstract:
The virus’ tricky, constantly mutating nature has so far made it impossible to develop an effective vaccine, even as the constantly improving antiviral drug classes have made HIV infection a manageable chronic health condition.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'HCV virus' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography